However, we observed a profound inter- and intratumoral heterogeneity of the expression of DEGs associated with the top enriched pathways in either primary tumor (hypoxia) or metastatic cells (MYC) (Supplemental Figure 2, H and I). The gene discussed is MYC; the disease is neoplasm.